Vor Biopharma (VOR) Change in Cash (2020 - 2026)

Vor Biopharma (VOR) has reported Change in Cash for 7 consecutive years, with -$226.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash fell 610.34% year-over-year to -$226.6 million; the TTM figure through Mar 2026 stood at $117.6 million (up 2213.22% YoY), while the FY2025 annual figure was $312.3 million, up 517.31% from the prior year.
• Change in Cash declined to -$226.6 million in Q1 2026 per VOR's latest filing, from $236.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $236.0 million in Q4 2025 and bottomed at -$226.6 million in Q1 2026.
• Historically, Change in Cash has averaged $2.8 million across 5 years, with a median of -$10.2 million in 2023.
• Annual changes were most pronounced in 2025 — Change in Cash soared 709.66% — and 2026, when it slumped 610.34%.
• Vor Biopharma's Change in Cash stood at -$3.1 million in 2022, then sank by 337.87% to -$13.7 million in 2023, then surged by 313.31% to $29.2 million in 2024, then jumped by 709.66% to $236.0 million in 2025, then tumbled by 196.01% to -$226.6 million in 2026.
• Business Quant data shows VOR's Change in Cash at -$226.6 million in Q1 2026, $236.0 million in Q4 2025, and -$32.4 million in Q3 2025.